introduction global incidence prevalence inflammatory bowel disease ibd increasing developed global scourge past year convincing development ibd result complex interaction genetic innate immune environmental factor several study confirmed gut microbiota play key role severity progression colitis patient ibd correcting intestinal flora imbalance important tool prevent treat colitis fecal microflora transplantation fmt probiotic administration currently main approach modify microbial composition gut fact probiotic food additive alternative fmt might promising clinical application due safer cheaper controllable however lack clinical effectiveness unclear molecular mechanism intervention render clinical application probiotic therapy problematic obviously seeking novel probiotic strain clarifying response mechanism highly significant bacteroides fragilis common gram-negative anaerobic bacterium found mainly colon characterized enterotoxin-producing bacteroides fragilis etbf non-enterotoxin-producing fragilis ntbf based ability synthesize secrete fragilis toxin bft etbf identified prevalent opportunistic pathogenic bacterium clinical infection promotes chronic inflammation thus lead crc contrast ntbf exhibit probiotic potential ranked candidate strain next generation promising probiotic may added edible list future widening array evidence demonstrated protection ntbf disease associated colon graft-versus-host disease gvhd bacterial diarrhea autism fragilis posse multiple metabolic potential various gene linked polysaccharide utilization implicated influencing host physiology regulating composition gut microbiota promoting production short-chain fatty acid scfas gut ntbf direct effect colonic epithelial cell enhancing barrier effect reducing membrane permeability inhibiting colonization pathogenic bacteria preferentially occupying colonic ecological niche maintain intestinal flora homeostasis also promotes development immune system secreting polysaccharide psa regulates immune response maintains immune homeostasis body addition ntbf also alleviate colonic inflammation inhibit tumorigenesis colon exact mechanism yet clear previous work analyzed gut microflora patient colonic adenomatous polyp found abundance bacteroides spp significantly decreased adenomatous polyp tissue relative healthy subject fragilis representative takaishi also observed marked loss fragilis group stool ibd patient one recent study berberine bbr modulatory effect dss-induced colitis possibly affecting growth fragilis regulate intestinal immune cell differentiation finding indicated fragilis might play crucial role protecting inflammatory bowel injury occurs ibd however precise protective role fragilis play underlying mechanism progression disease completely understood therefore study aim investigate protective effect fragilis colitis underlying mechanism cellular animal level result fragilis show stronger adhesion lovo cell hcoepic bacteria adhere host cell exert direct ecological effect physiological action microscopic morphology fragilis atcc25285 observed co-culture cell suspension diluted time counted result indicated fragilis adhering lovo cell significantly higher normal colonic epithelial cell hcoepic 0.05 however fragilis detected crushed cell suspension subsequently cultivation time prolonged still failed detect invasive bacteria cell morphology unchanged growth status positive compared group addition bacterium conclusion adhesion invasion assay demonstrated fragilis atcc25285 adhered better lovo cell hcoepic cell never showed invasion strain table table comparison adhesion invasion ability fragilis hcoepic lovo cell full size table protective effect fragilis tnf-α-induced impairment cell activity impact fragilis atcc25285 tnf-α cell motility initially evaluated took fragilis solution od600 diluted time counted colony plate 10.15 colony obtained converted concentration approximately 1.03 cfu/ml fig subsequently various concentration fragilis cell co-cultured indicated fragilis concentration moi 108.68 3.0 moi 98.82 1.4 toxicity cell 0.05 however moi fragilis caused significant decrease survival rate two strain cell 68.26 2.3 0.001 fig cell viability decreased gradually increasing tnf-α concentration ng/ml tnf-α significantly reduced viability cell 63.02 0.9 0.001 fig therefore maximum bacterial concentration effect cell moi tnf-α concentration ng/ml influential cell survival used optimal experimental condition figure optimal concentration fragilis tnf-α determined cck8 trial designed select optimal concentration fragilis tnf-α respectively result fragilis plate counting method cfu/ml cell viability hcoepic cell co-cultured different concentration fragilis tnf-α respectively 0.001 significant data show mean sem cck-8 cell counting kit-8 full size image estimate role fragilis atcc25285 tnf-α-induced hcoepic activity cell viability damage examined cck8 assay ldh release assay treatment cell fragilis affect cell survival compared addition bacteria indicating fragilis alone impair cell activity 0.05 consistently tnf-α treatment significantly reduced cell survival 71.61 2.96 0.001 unexpected fragilis rescued injury 98.21 2.95 0.001 fig addition ldh released extracellularly cell damage death therefore cell culture supernatant taken detect extracellular ldh release result consistent cck8 assay fragilis decreased extracellular ldh activity compared tnf-α treatment alone despite significant difference hcoepic cell 0.05 fig finding suggested fragilis atcc25285 protective effect tnf-α-induced impairment cell viability hcoepic cell figure protective effect fragilis tnf-α-induced impairment cell activity cell survival individual combined treatment 1×10 cfu/ml ng/ml tnf-α lactate dehydrogenase activity cell culture supernatant 0.001 0.01 0.05 significant data show mean sem fragilis tnf-α tumor necrosis factor-α full size image fragilis inhibits tnf-α-induced apoptosis hcoepic cell meanwhile also examined influence fragilis atcc25285 tnf-α-induced apoptosis hcoepic cell fig show late apoptotic early apoptotic cell located quadrant respectively analysis revealed effect fragilis treatment alone apoptosis cell hcoepic compared control group 1.89 0.42 0.05 tnf-α treatment alone significantly promoted apoptosis 3.48 1.15 0.05 treatment fragilis prior tnf-α induction led reduction apoptosis hcoepic cell statistically significant 2.48 0.50 0.05 apoptosis assay demonstrated co-culture fragilis atcc25285 cell impact apoptosis tend reduce tnf- induced apoptosis figure fragilis inhibited apoptosis restored migration hcoepic cell induced tnf-α apoptosis rate valued flow cytometry hcoepic cell treated fragilis tnf-α alone together late apoptotic early apoptotic cell located quadrant respectively apoptosis rate hcoepic cell migration rate hcoepic cell 0.001 0.01 0.05 significant data show mean sem full size image fragilis restores tnf-α-induced migration hcoepic cell explore role fragilis atcc25285 migration colon epithelial cell presence absence tnf-α evaluated level cell scratch healing fragilis promoted migration hcoepic cell compared control 0.05 consistently ng/ml tnf-α stimulation resulted inhibition migratory capacity hcoepic cell 0.001 notably fragilis stimulated migration cell compared tnf-α treatment alone statistically significant increase migration hcoepic cell 0.001 shown fig conclusion data demonstrated fragilis atcc25285 likely promote migration normal colonic epithelial cell restore tnf-α-induced reduction migratory capacity hcoepic cell fragilis playes protective role tnf-α-induced inflammation nf-κb widely expressed transcription factor play important role regulating immune inflammatory response programmed cell death given benefit fragilis colonic inflammation thus speculated fragilis atcc25285 could regulate nf-κb pathway consequently probed modulation nf-κb pathway fragilis tnf-α-induced inflammatory response vitro cellular assay expression nf-κb p65 p-nf-κb p65 iκbα p-iκbα key protein nf-κb pathway next analyzed context tnf-α induction result showed tnf-α stimulation alone markedly increased expression p-nf-κb p65 p-iκbα compared control group indicating tnf-α activated nf-κb signal 0.05 shown fig surprisingly fragilis down-regulated expression p-nf-κb p65 p-iκbα induced tnf-α indicating fragilis atcc25285inhibited activation nf-κb signalling induced tnf-α figure fragilis inhibits activation nf-κb inflammatory pathway induced tnf-α western blot analysis showed fragilis reduced high expression nf-κb pathway related protein p-p65 t-p65 p-iκbα t-iκbα induced tnf-a β-actin used indicator protein loading relative nf-κb mrna iκb-α mrna level valued rt-qpcr assay 0.001 0.01 0.05 significant data show mean sem original western blot image visible supplementary material full size image determine potential protective effect fragilis atcc25285 tnf-α-induced inflammation concentration nf-κb pathway-related cytokine il-6 il-8 il-10 il-1β measured treatment cell fragilis mildly inhibited expression pro-inflammatory cytokine il-6 il-8 il-1βcompared control group statistically significant difference except decrease il-6 hcoepic cell 0.05 contrast fragilis gently facilitated production il-10 cytokine inhibits inflammation statistically significant increase il-10 expression hcoepic cell 0.05 concurringly tnf-α stimulation alone led significant increase pro-inflammatory cytokine il-6 il-8 il-1β 0.05 effect inhibited fragilis similarly fragilis also inhibited reduction anti-inflammatory factor il-10 hcoepic cell caused tnf-α 0.05 finding pointed ability fragilis atcc25285 inhibit tnf-α-induced production pro-inflammatory cytokine il-1β 0.001 enhance generation anti-inflammatory cytokine il-10 0.01 hcoepic fig a–d furthermore tlrs natural receptor microorganism shown target action fragilis however whether fragilis affect tnf-α-activated inflammation tlr receptor known therefore examined expression tlr2 tlr4 downstream protein myd88d hcoepic cell treated fragilis atcc25285 shown fig e–h fragilis treatment alone mildly up-regulated tlr2 protein 0.05 down-regulated expression tlr4 myd88 0.05 epithelial cell compared control effect fragilis atcc tlr2 tlr4 expression tnfa-stimulated hcoepic cell unclear figure fragilis inhibited tnf-α-induced generation inflammation-associated cytokine culture supernatant collected value concentration cytokine il-6 il-8 il-10 il-1β enzyme-linked immunosorbent assay expression tlr2 tlr4 myd88 valued western blot rt-qpcr molecular protein level 0.001 0.01 0.05 significant data show mean sem original western blot image visible supplementary material full size image fragilis culture supernatant attenuates tnf-α-induced cell death inflammatory response determine whether fragilis atcc25285 metabolite also involved protective efficacy extracted culture supernatant fragilis analyzed supernatant tnf-α-induced cellular damage inflammatory effect illustrated fig finding showed fragilis culture supernatant similarly rescued tnf-α-induced cell activity decreasing 0.01 fig also assessed alteration inflammatory factor demonstrated fragilis atcc25285 supernatant inhibited tnf-α-induced high expression il-1β il-6 hcoepic cell furthermore enhanced production anti-inflammatory factor il-10 even though statistical difference observed yet significantly promoted il-10 expression hcoepic cell relative tnf-a treatment 0.001 fig b–e unlike fragilis treatment supernatant facilitated il-8 expression cell 0.05 displayed superimposed effect tnf-a showing fragilis atcc25285 supernatant led higher il-8 expression cell relative tnf-α effect alone 0.05 figure fragilis culture supernatant attenuates tnf-α-induced cell death inflammatory response cell survival rate hcoepic cell culture supernatant collected value concentration cytokine il-6 il-8 il-10 il-1β enzyme-linked immunosorbent assay 0.001 0.01 0.05 significant data show mean sem bfs fragilis supernatant full size image fragilis alleviates phenotype dss-induced acute colitis ass anti-inflammatory effect fragilis atcc25285 vivo established murine model acute colitis using induction feeding mouse phosphate-buffered saline fragilis atcc25285 live hyperbaric inactivated bacteria day followed day colitis induction 2.5 drinking water freely fig body weight food intake water consumption diarrhoeal score mouse measured every day exclude difference daily diet water intake observed difference daily dietary intake among three group fig excludes error due consumption result showed mouse fed activated- fragilis showed weight loss fig lower dai score fig control group inactivated- fragilis similar effect extent blood stool significantly alleviated mouse activated-bf group throughout experimental period moreover activated-bf group showed trend towards lower intestinal inflammation colon length spleen weight similar statistically figure fragilis alleviated dss-induced colon injury scheme animal experimental design mouse assigned three group randomly activated-bf inactivated-bf mouse continuously administered fragilis day colitis induced drinking 2.5 day day mouse sacrificed daily water intake diet mouse percentage mouse weight change day to7day disease activity index dai score calculated time colon length weight spleen fragilis administration left representative colon group right score data data shown mean sem 0.001 0.01 0.05 full size image distinct compared group fig pathological staining indicated colonic tissue mouse group showed local tissue ulceration absence mucosal epithelial intestinal glandular structure submucosal oedema severe infiltration mucosa submucosa even inflammatory cell leading higher histological score fig mouse activated-dss group improved histological damage compared group showing mucosal damage well submucosal inflammatory cell infiltration leading significantly lower histological score effect inactivated- fragilis effective activated- fragilis result suggested activated- fragilis atcc25285 attenuated clinical symptom dss-induced colitis mouse rather inactivated- fragilis fragilis enhances intestinal tight junction protein exhibit intestinal anti-inflammatory effect gut mucosal barrier first barrier hostile environment key role development ulcerative colitis mainly formed epithelial junction tight junction composed transmembrane protein ocludins claudins auxin prevent spread pathogen harmful antigen within epithelium expression tight junction protein zo1 claudin occludin muc2 analyzed colonic tissue section ihc result showed colon tissue group presented increased structure defect destroyed crypt disrupted apicalregion mean optical density protein shallow protein distribution diffuse discontinuous group indicating low expression fig moreover level protein expression remarkably increased fragilis atcc25285 treatment group figure fragilis enhances intestinal tight junction protein exhibited intestinal anti-inflammatory effect ihc staining colon scale bar concentration zo-1 claudin1 occluding muc2 colon intestinal permeability measured determining plasma concentration fitc-dextran colonic cytokine expression il-6 tnf-α il-1β il10 intestinal tight junction protein expression data shown mean sem 0.001 0.01 0.05 full size image hand also determined mrna expression tight junction protein found fragilis atcc25285 treatment significantly increased expression zo1 0.024 occludin 0.027 claudin-1 0.009 relative group fig .then intestinal permeability measured determining plasma concentration fitc-dextran notably fitc-dextran analysis showed decreased intestinal permeability mouse fragilis atcc25285 group compared group suggesting increased barrier function following fragilis treatment 0.001 fig evaluated alteration inflammatory factor showed fragilis significantly declined inflammatory factor il-6 0.045 tnf-α 0.012 relative treatment expression anti-inflammatory factor il-10 0.001 increased fig d–g discussion finding showed fragilis atcc25285 reduced tnf-α-induced colonic cell injury promoted colonic epithelial cell migration vitro preliminarily demonstrated fragilis might fight tnf-α-induced inflammation down-regulating nf-κb pathway reducing release pro-inflammatory factor il-6 il-1β increasing production anti-inflammatory factor il-10 notably also found culture supernatant fragilis atcc25285 equally anti-inflammatory shown fig clarify anti-inflammatory effect fragilis intervened dss-induced colitis mouse live fragilis hyperbaric-inactivated dead strain result indicated live fragilis inactivated bacteria alleviated colitis mouse study elucidates anti-inflammatory effect fragilis atcc25285 different model vivo vitro note fragilis atcc25285 metabolite may key exerting anti-inflammatory effect fragilis constitutes human intestinal flora profound impact host physiology recently ntbf shown exert beneficial effect host health promoting immune system maturation suppressing abnormal inflammation altering structure intestinal flora revealed fragilis atcc25285 could adhere tumor cell lovo normal colonic epithelial cell hcoepic adhesion tumor cell significantly higher normal colonic epithelial cell indicating fragilis atcc25285 different adhesion ability different colonic cell specific adhesion selection mechanism clear adhesion ability may associated abundant hair structure ability bacterium secrete adhesion molecule laminin several report indicated adherence fragilis colonic cell promotes mucin expression enhances intestinal epithelial barrier function secreted bacteriostatic substance form chemical barrier strengthens cellular barrier function fragilis could also accumulate surface colonic cell adhesion forming protective biofilm han identified smectite ion-exchange microstructure preferentially promotes biofilm formation surface probiotic bacteria inside outside body smectite carrying probiotic biofilm able activate dendritic cell via tlr2 signaling mouse model inhibit tumor growth however invasion assay revealed fragilis atcc25285 exhibit invasive property two cell strain alteration cell morphology activity occurred co-culture bacteria cell outcome initially suggest fragilis atcc25285 harmful cell tnf-α take important role development inflammation therefore chose tnf-α stimulation establish vitro cellular inflammation model result suggested tnf-α led lower cell viability higher ldh release apoptosis significant wrinkling rupture microscopic morphology however fragilis atcc25285 inhibited cell death damage caused tnf-α similar study found fragilis inhibited ht29 apoptosis intestinal epithelial-like cell another study fragilis zy-312 proven inhibit apoptosis-induced cell death downregulating apoptosis-associated protein addition fragilis able restore functional integrity intestinal barrier thus effect fragilis atcc25285 tnf-α-induced cell migration also evaluated study identified tnf-α inhibited migration hcoepic cell probably due significant inhibition cellular activity tnf-α concentration ng/ml leading decrease migration rate similar study petito found tnf-α inhibited migratory ability iec-6 caco2 cell contrast fragilis atcc25285 treatment alone significantly increased migration normal colonic epithelial cell hcoepic promotion colonic epithelial cell migration fragilis atcc25285 likely key factor able restore intestinal mucosal barrier however pre-colonization fragilis atcc25285 accelerated tnf-α-induced cell migration may related protective effect inhibiting tnf-α-induced cell injury nf-κb ubiquitously expressed transcription factor act critical regulator immune inflammatory response programmed cell death result showed nf-κb signaling pathway slightly activated statistically significant treatment fragilis atcc25285 alone however high expression phosphorylated nf-κb p65 iκbα caused tnf-α significantly down-regulated indicating fragilis could inhibit activation nf-κb signaling pathway induced tnf-α protective effect fragilis atcc25285 largely psa dependent manner evidence ntbf lacking psa basically loses protective activity fragilis may secrete beneficial metabolite n-3 polyunsaturated fatty acid short chain fatty acid regulate nf-κb signaling pathway thus exerting anti-inflammatory tumor suppressor activity butyrate major short chain fatty acid important source energy epithelial cell could regulate cell differentiation apoptosis inhibiting intestinal inflammation development crc yin reported pre-treatment ht-29 sw480 sw620 cell butyric acid could inhibit tnf-α-mediated nuclear translocation nf-κb p65 nf-κb p50 degradation iκbα possibly due inhibition deacetylase capacity addition butyrate down-regulated nf-κb signaling pathway reduce inflammation rat colitis experiment reduce expression pro-inflammatory cytokine intestinal biopsy patient crohn disease also reduced neuritis effect alzheimer disease inhibition nf-κb pathway also examined effect fragilis atcc25285 expression tnf-α-induced inflammatory factor result showed expression tnf-α-induced il-6 il-1β pro-inflammatory factor suppressed fragilis il-10 anti-inflammatory cytokine il-10 knockout mouse could spontaneously develop colonic inflammation accompanied increased intestinal permeability various pro-inflammatory cytokine study found fragilis could promote secretion il-10 hcoepic cell possible reason psa secreted fragilis induces expression il-10 regulating immune response thereby inhibiting inflammation consistent mazmanian round found fragilis could protect animal helicobacter pylorus infection reduce colonic inflammation activating regulatory cell promoting secretion il-10 effectively inhibit production pro-inflammatory factor il-17 thus result suggest protective effect fragilis inflammation related secretion il-10 promisingly culture supernatant fragilis appears similar effect suppressing high expression il-1β il-6 induced tnf-α increasing anti-inflammatory factor il-10 whereas conversely promoting superimposing expression il-8 induced tnf-a indicating mechanism anti-inflammatory effect exerted fragilis metabolite might distinct recent study bernhard investigated composition strain probiotic bacteria omni bio®aad10 effect supernatant cultivation shown supernatant bacteria excellent antibacterial antifungal effect promoted growth different bacteria vivo yet remains unclear whether probiotic effect triggered bacteria bacterial metabolites/components short-chain fatty acid scfa secondary bile acid molecular pattern associated microorganism e.g lipopolysaccharides peptidoglycans problem drive field postbiotic research research clarified metabolite act mechanism action research needed tlrs family essential inflammatory response recognizing conserved pathogen-associated molecular pattern pamps tlr2 tlr4 important member family reported related anti-inflammatory effect fragilis specific mechanism clearly understood till study shown tlr2 involved protection psa colitis autoimmune encephalomyelitis tlr4 important receptor innate immune recognition bacterial role remains controversial fragilis could induce high expression tlr4 omvs outer membrane vesicle omvs significantly increase anti-inflammatory cytokine caco-2 cell line study showed fragilis atcc25285 treatment alone mildly up-regulated tlr2 protein 0.05 down-regulated expression tlr4 myd88 0.05 epithelial cell compared control effect fragilis atcc tlr2 tlr4 expression tnfa-stimulated hcoepic cell unclear speculate possibly inflammation induced fragilis response tnf-a mediated tlr receptor tlr receptor may relevant lps-induced inflammation bacterial origin.this similar ahmadi finding stimulated caco-2 cell fragilis omvs mrna level tlr2 significantly decreased mrna level tlr4 slightly increased thus increasing expression anti-inflammatory cytokine besides one study reported psa secreted fragilis could induce treg cell express il-10 reduce inflammation response nod2 atg16l1 dependent manner however another studie also showed fragilis played protective role viral infection tlr4-induced ifn-β secretion independent tlr2 lee also reported tlr4 receptor mediates inhibitory effect fragilis aom/dss-induced colon carcinogenesis mouse together result suggest tlr2 tlr4 may involved anti-inflammatory effect fragilis conclusion cellular experiment demonstrated fragilis atcc25285 could counteract tnf-a-induced inflammatory response normal colonic epithelial cell notably also found culture supernatant fragilis atcc25285 equally anti-inflammatory clarify anti-inflammatory effect fragilis colonic epithelial cell notably also found culture supernatant fragilis atcc25285 equally anti-inflammat metabolic supernatant obtained dead fragilis organism high pressure explored action live dead bacteria body colonitis mouse currently gold standard field enterocolitis modelling advantage modelling consists fact symptom sign pathological feature model animal identical human ulcerative colitis commonly used model studying inflammatory mechanism anti-inflammatory drug human thus performed animal experiment ass role fragilis atcc25285 dss-induced acute colitis result demonstrated preimplantation living fragilis atcc25285 rather dead strain effective alleviating weight loss colonic shortening caused reducing diarrhoea score increasing expression tight junction protein well decreasing inflammatory factor zheng explored effect berberine bbr intestinal bacteria inflammatory response induced mouse colitis bbr eliminated dss-induced intestinal flora disturbance mouse particularly increased fragilis vivo vitro fragilis decreased interleukin-6 induced dendritic cell heat-resistant component rather nucleic acid protein study demonstrated high abundance fragilis may contribute resistance dss-induced colitis mouse large part anti-inflammatory effect fragilis may attributed active substance metabolism living bacteria body fragilis -mediated protective mechanism complex extracellular vesicle fragilis outer membrane psa also effective nf-κb-mediated inflammation confined colon disease addition fragilis colonization-induced intestinal metabolite scfa modulates immune cell development treg intestinal permeability vivo vitro study revealed fragilis atcc25285 inhibited nf-κb signalling pathway pro-inflammatory factor tnf-α-induced inflammatory cell model effect doe appear mediated tlr receptor however characterise study whether anti-tnf-induced inflammatory effect fragilis dependent psa given importance psa construction psa-deficient fragilis strain clarify anti-inflammatory mechanism necessary future study notable found fragilis atcc25285 frontal culture supernatant equally effective tnf-a-induced cellular inflammation subsequent gavage inactivated bacteriophage dss-induced colitis mouse show efficacy finding revealed active component culture supernatant fragilis atcc25285 may key anti-inflammatory effect future study isolate active component metabolised specie fragilis investigate functional mechanism would significance conclusion conclusion shown anti-inflammatory effect fragilis vivo vitro experiment result supported fragilis promising probiotic candidate colitis-related disease treatment future mechanism‐based interaction host gut microbiota human trial needed confirm long‐term safety efficacy fragilis finding highlight fragilis potential next-generation probiotic strain assist treatment inflammatory disease colon characterization probiotic property strain level offer opportunity find novel strategy microbiome therapeutic material method bacterial strain culture condition bacteroides fragilis strain atcc25285 purchased american type culture collection atcc manassas usa strain cultured brain heart infusion bhi broth anaerobically anaerobic environment containing bhi supplemented 0.0005 hemin 0.5 mg/ml vitamin optimal growth bhis fragilis centrifuged washed three time sterile solution adjusted cfu/ml sterile measuring optical density using spectrophotometer thermo usa culture supernatant fragilis filtered 0.25 filter prepared usage co-culture processing fragilis cell human normal colonic epithelial cell hcoepic colonic adenocarcinoma epithelial cell lovo kindly donated kunming institute zoology chinese academy science two cell cultured rpmi medium fetal bovine serum fbs penicillin/streptomycin humidified atmosphere recombinant human tnf-αlpha tnf-α dissolved adjusted concentration μg/ml stored cell 80–90 confluence detached culture plate using 0.25 trypsin–edta solution passage cell used different assay specific experimental grouping follows control group fragilis group co-cultured hcoepic fragilis concentration cfu/ml moi tnf-α induction group hcoepic cell treated ng/ml tnf-α fragilis tnf-α group cell co-cultured fragilis firstly tnf-α added treat cell animal experiment animal experiment approved animal care use committee kunming medical university protocol code kmmu20221532 july yunnan china performed accordance university guide care use laboratory animal figure schematic diagram experimental protocol 6–8-week-old male c57bl/6 mouse purchased department zoology kunming medical university group mouse housed isolation cage kept following automatically controlled condition light light dark temperature relative humidity day acclimatization feeding mouse placed one following group dss-control activated- fragilis inactivated- fragilis fragilis including live organism high pressure obtain dead cell strain.these mouse administered respectively 200µl suspension per mouse fragilis cfu/ml every day week suspension given oral gavage induce experimental acute colitis mouse two group provided drinking water containing low-molecular-weight 2.5 molecular weight 36,000–50,000 biomedicals solon additional week 3-wk study period daily clinical assessment dss-induced colitis performed including measuring body weight food intake noting rectal bleeding stool condition blood stool using disease activity index dai scoring system dai score calculated score loss none stool consistency normal soft stool soft stool watery stool diarrhea stool blood negative positive positive positive visible rectal bleeding judgment degree positivity followed instruction provided manufacturer week mouse killed downstream experiment pathological analysis colon tissue fixed formalin embedded paraffin section stained pathological analysis scale used describe severity inflammation absent mild moderate severe degree inflammatory involvement absent mucosal mucosal submucosal transmural extent epithelial/cryptal damage absent basal 1/3 basal 2/3 loss crypt destruction crypt surface epithelium parameter calculated summed obtain mean value fitc-dextran intestinal permeability assay mouse fasted water food 7th day 2.5 treatment gavaged 0.6 mg/g fitc-dextran per mouse blood taken eyeball mouse placing dark environment centrifuged for15min rpm/min supernatant sample taken add 50ul 50ul serum tested black opaque 96-well plate detect value spectrophotometer excitation wavelength nm/emission wavelength higher content represents better intestinal permeability intestinal barrier severely damaged immunohistochemistry paraffin-embedded tissue section rehydrated antigenically repaired using sodium citrate buffer section incubated overnight primary antibody targeting zo1 occludin claudin muc2 servicebio china 1:1000 dilution section washed subsequently incubated goat anti-rabbit igg-peroxidase servicebio china 1:1000 dilution min room temperature washing section stained dab finally section dehydrated made transparent xylene fixed neutral gum bacterial adhesion assay hcoepic lovo cell seeded cell per well 12-well tissue culture plate cell washed three time sterile remove residual serum antibody antibodie-free rpmi medium containing fbs added well equal volume fragilis co-cultured cell ratio moi incubator cell washed three time 0.5 triton-x100 added cell lysed min another sterile distilled water added mixed diluted time total bacterial solution evenly spread columbia blood agar plate incubated anaerobic environment colony number counted invasion assay hcoepic lovo cell co-cultured fragilis moi described previously subsequently cell washed time rpmi basal medium comprising 100ug/ml gentamicin added incubated incubator kill extracellularly attached bacteria cell treated 0.5 triton-x100 lysed min immediately neutral distilled water added mixed stock solution laid columbia blood agar plate colony counted cck assay cell well growth status seeded 96-well plate density per well incubated incubator later cell treated various concentration grade fragilis moi moi moi tnf-α ng/ml ng/ml ng/ml ng/ml cell viability detected cck8 reagent kit proteintech wuhan china select optimum experimental concentration addition cell treated optimal concentration grouping mentioned cell viability tested measured accordingly brief cell treated indicated cck-8 solution added culture medium incubated another cell activity measured using microplate reader ldh release assay cell damage demise trigger release lactate dehydrogenase ldh extracellular compartment measurement extraneous ldh activity help ass cell damage death ldh catalyzes production pyruvate lactate produce absorption peak color shade proportional pyruvate concentration thus ldh activity calculated measuring value specifically cell inoculated 6-well plate density per well incubated treated described followed collection cell culture supernatant assay ldh kit elabscience wuhan china used ass cell injury according manufacturer protocol absorbance value obtained using enzyme-labeled instrument thermo usa flow cytometric analysis annexin v/pi apoptosis detection kit keygen nanjing china used ass cell apoptosis short preparation seeding hcoepic cell density cells/ml 6-well plate later cell treated fragilis tnf-α alone combination described term grouping single cell suspension prepared centrifuged min suspension collected washed re-suspended binding buffer containing fitc-annexin propidium iodide gently vortexed cell incubated dark min degree cell apoptosis assessed flow cytometry bioscience usa based manufacturer instruction scratch assay scratch assay done previously reported briefly cell monolayer formed plate scraped tip 100μl sterile pipette isolated cell washed latter wound width observed photographed wound healing rate different treatment group collected calculated quantitative real time polymerase chain reaction qrt-pcr total rna hcoepic cell isolated using total rna extraction kit tiangen beijing china according manufacturer detected concentration purity integrity rna rna reverse transcripted cdna 5xall-ln-one mastermix kit abm canada tlr2 tlr4 myd88 nf-κb iκbα il-6 il-10 il-1β tnf-α zo1 occludin claudin-1 muc2 quantified using sybr green pcr master mix tiangen beijing china light cycler real-time pcr detection system roche molecular system inc reaction condition follows pre-denaturation min followed cycle denaturation annealing extension β-actin included internal reference data analyzed method primer sequence gene exhibited additional file1 western blotting protein expression measured western blotting analysis cell lysed ice-ripa lysis buffer containing protease inhibitor supernatant separated cell debris using centrifugation 14,000 rpm min protein quantified using bicinchoninic acid bca method sodium dodecyl sulfate polyacrylamide gel electrophoresis sds-page used separate protein extracted protein transferred polyvinylidene fuoride pvdf membrane blocking 2.5 w/v skimmed dry milk tris-buffered saline containing 0.1 tween-20 tbst room temperature membrane washed incubated appropriate primary antibody 1:1000 dilution tlr2 tlr4 myd88 nf-κb p65 p-nf-κb p65 iκbα p-iκbα 1:5000 dilution β-actin w/v bsa tbst incubated overnight membrance washed three time tbst incubated secondary antibody goat anti-rabbit igg 1:5000 room temperature reaction band detected using enhanced chemiluminescence ecl gendepot katy usa observed using chemiluminescence imaging system healthcare beijing china elisa assay culture supernatant collected 6-well plate concentration cell cytokine il-6 il-8 il-10 il-1β valued using enzyme-linked immunosorbent assay elisa kit proteintech wuhan china normalized cell protein concentration assay carried protocol supported individual manufacturer statistical analysis statistical calculation performed using spss 19.0 software graphpad prism 6.0 software result shown mean standard error mean sem statistical difference experimental group evaluated student test one-way analysis variance anova followed post hoc analysis using lsd comparison test multiple comparison value 0.05 considered statistically significant institutional review board statement animal experiment approved animal care use committee kunming medical university protocol code kmmu20221532 july yunnan china performed accordance university guide care use laboratory animal